Increase in Plasma Glucose Lowering Action of Rosiglitazone by Electroacupuncture at Bilateral Zusanli Acupoints (ST.36) in Rats

JAMS Journal of Acupuncture and Meridian Studies

Volumn 2, Issue 2, 2009, Pages 147-151

  Pai, Hui Ching ^a   Tzeng, Chung Yuh ^b   Lee, Yu Chen ^c   Chang, Chin Hsien ^d   Lin, Jaung Geng ^a   Cheng, Juei Tang ^a,e   Chang, Shih Liang ^a,f  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^f DA YEH UNIVERSITY   (Taiwan)

Author keywords

electroacupuncture; insulin; plasma glucose; rosiglitazone; type 2 diabetes mellitus

Indexed keywords

BETA ENDORPHIN; GLUCOSE; INSULIN; ROSIGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ELECTROACUPUNCTURE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TREATMENT OUTCOME; ZUSANLI ACUPOINT; ACUPUNCTURE; ANIMAL; DIABETES MELLITUS, TYPE 2; DISEASE MODEL; HUMAN; METABOLISM; MULTIMODALITY CANCER THERAPY; RANDOMIZATION; WISTAR RAT;

ACUPUNCTURE POINTS; ANIMALS; BLOOD GLUCOSE; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; ELECTROACUPUNCTURE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR; THIAZOLIDINEDIONES;

EID: 67651089810     PISSN: 20052901     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2005-2901(09)60047-9     Document Type: Article

References (21)

1. Lin J.G., Chen W.C., Hsieh C.L., Tsai C.C., Cheng Y.W., Cheng J.T., and Chang S.L. Multiple sources of endogenous opioid peptide involved in the hypoglycemic response to 15 Hz electroacu-puncture at the Zhongwan acupoint in rats. Neurosci Lett 366 (2004) 39-42
2. Chang S.L., Lin K.J., Lin R.T., Hung P.H., Lin J.G., and Cheng J.T. Enhanced insulin sensitivity using electroacupuncture on bilateral Zusanli acupoints (ST 36) in rats. Life Sci 79 (2006) 967-971
3. Shapira M.Y., Appelbaum E.Y., Hirshberg B., Mizrahi Y., Bar-On H., and Ziv E. A sustained, non-insulin related, hypoglycaemic effect of electroacupuncture in diabetic Psammomys obesus. Diabetologia 43 (2000) 809-813
4. Senna-Fernandes V., França D., Moreno S.F., Santos-Filho S., Rogers P.A., Bernardo-Filho M., and Guimarães M.A. The effect of "Zusanli" (ST. 36) acupuncture on the bio-availability of sodium pertechnetate in Wistar rats. Acupunct Electrother Res 31 (2006) 33-44
5. Khawaja X.Z., Green I.C., Thorpe J.R., and Titheradge M.A. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain. Biochem J 267 (1990) 233-240
6. Bruni J.F., Watkins W.B., and Yen S.S. Beta-endorphin in the human pancreas. J Clin Endocrinol Metab 49 (1979) 649-651
7. Curry D.L., Bennett L.L., and Li C.H. Stimulation of insulin secretion by beta-endorphins (1-27 & 1-31). Life Sci 40 (1987) 2053-2058
8. Chang S.L., Lin J.G., Chi T.C., Liu I.M., and Cheng J.T. An insulin-dependent hypoglycaemia induced by electroacupuncture at the Zhongwan (CV12) acupoint in diabetic rats. Diabetologia 42 (1999) 250-255
9. Lin J.G., Chang S.L., and Cheng J.T. Release of beta-endorphin from adrenal gland to lower plasma glucose by the electroacupuncture at Zhongwan acupoint in rats. Neurosci Lett 326 (2002) 17-20
10. Liao Y.Y., Seto K., Saito H., and Kawakami M. Effects of acupuncture on the citrate and glucose metabolism in the liver under various types of stress. Am J Chin Med 8 (1980) 354-366
11. Wang S.J., Xu H.Z., and Xiao H.L. Effect of high-frequency electroacupuncture on lipid metabolism in obesity rats. Zhen Ci Yan Jiu 33 (2008) 154-158 [In Chinese]
12. Li C.R., You X.F., and Jiang J.D. Advance in diabetes animal models. Chinese Journal of Comparative Medicine 15 (2005) 59-63 [In Chinese]
13. Kodama T., Iwase M., Nunoi K., Maki Y., Yoshinari M., and Fujishima M. A new diabetes model induced by neonatal alloxan treatment in rats. Diabetes Res Clin Pract 20 (1993) 183-189
14. Blondel O., Bailbe D., and Portha B. Relation of insulin deficiency to impaired insulin action in NIDDM adult rats given streptozocin as neonates. Diabetes 38 (1989) 610-617
15. Bonner-Weir S., Trent D.F., Honey R.N., and Weir G.C. Responses of neonatal rat islets to streptozotocin: limited B-cell regeneration and hyperglycemia. Diabetes 30 (1981) 64-69
16. Takada J., Machado M.A., Peres S.B., Brito L.C., Borges-Silva C.N., Costa C., Fonseca-Alaniz M.H., Andreotti S., and Lima F.B. Neonatal streptozotocin-induced diabetes mellitus: a model of insulin resistance associated with loss of adipose mass. Metabolism 56 (2007) 977-984
17. Trent D.F., Fletcher D.J., May J.M., Bonner-Weir S., and Weir G.C. Abnormal islet and adipocyte function in young B-cell-deficient rats with near-normoglycemia. Diabetes 33 (1984) 170-175
18. Ciaraldi T.P., Gilmore A., Olefsky J.M., Goldberg M., and Heidenreich K.A. In vitro studies on the action of CS-045, a new antidiabetic agent. Metabolism 39 (1990) 1056-1062
19. Yki-Jarvinen H. Thiazolidinediones. N Engl J Med 351 (2004) 1106-1118
20. Porstmann T., and Kiessig S.T. Enzyme immunoassay techniques. An overview. J Immunol Methods 150 (1992) 5-21
21. Reed M.J., Meszaros K., Entes L.J., Claypool M.D., Pinkett J.G., Gadbois T.M., and Reaven G.M. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49 (2000) 1390-1394